Physician

Matthew J. Bream, MD

According to 2025 Medicare claims, Matthew Bream, MD (NPI: 1356609549) practices urology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is UROLOGICAL ASSOCIATES PC (NPI: 1346229192; TIN: 420987062) and primary practice location at 52807-2125. Bream is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Bream's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 580 traditional Medicare patients, billed 12,037 HCPCS/CPT codes, and received $259,831 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,103 prescription claims across 360 beneficiaries totaling $90,497 in drug costs, led by Orgovyx (Relugolix). DME data shows 239 claims. Open Payments data shows 4 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,905 to $90,497. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	321	4,211	$84,744
2019	594	11,661	$257,174
2020	589	12,816	$258,310
2021	566	14,601	$460,421
2022	452	8,468	$265,291
2023	507	13,027	$254,267
2024	580	12,037	$259,831

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	53	$1,905
2016	49	71	$1,749
2017	99	161	$1,405
2018	167	356	$12,538
2019	334	1,142	$45,872
2020	317	977	$38,282
2021	304	853	$31,542
2022	324	959	$71,872
2023	344	958	$113,577
2024	360	1,103	$90,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	38	56	$481
2019	89	142	$1,296
2020	90	170	$5,577
2021	101	268	$29,984
2022	112	257	$21,966
2023	103	229	$25,770
2024	87	239	$36,224

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	104	123	$145
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	100	100	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	150	196	$86
36415	Insertion of needle into vein for collection of blood sample	121	160	$9
81001	Manual urinalysis test with examination using microscope, automated	264	387	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	22	658	$56,720
Xarelto	Rivaroxaban	13	397	$7,985
Tamsulosin Hcl	Tamsulosin Hcl	490	27,302	$6,898
Oxybutynin Chloride Er	Oxybutynin Chloride	113	5,050	$1,535
Silodosin	Silodosin	20	780	$955

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	33	$23,429
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	11	52	$11,515
A4402	Lubricant, per ounce	N	15	60	$391
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	24	36	$309
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	22	28	$304

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$82	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew J. Bream, MD?

Tedicare shows public-source Medicare data for Matthew J. Bream, MD (NPI 1356609549), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew J. Bream, MD have ACO affiliation data?

Matthew J. Bream, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Matthew J. Bream, MD?

Matthew J. Bream, MD is linked to UROLOGICAL ASSOCIATES PC (billing NPI 1346229192) in the available physician profile data.

Does Matthew J. Bream, MD have Open Payments data?

Matthew J. Bream, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.